neurodegenerative

(redirected from Neurodegenerative disease)
Also found in: Medical, Encyclopedia, Wikipedia.

neu·ro·de·gen·er·a·tive

 (no͝or′ō-dĭ-jĕn′ər-ə-tĭv, nyo͝or′-)
adj.
Of, relating to, or characterized by a progressive loss of neurons in the brain: neurodegenerative diseases.
References in periodicals archive ?
The collaboration is focused on using [F-18]MK-6240 as a biomarker in Janssen neurodegenerative disease research studies.
NEW ORLEANS - The use of metformin for at least 2 years had a protective effect on the incidence of neurodegenerative disease among elderly veterans, according to results from a large analysis of Veterans Affairs data.
com)-- Neurodegenerative disease or neurodegeneration refers to the progressive damage or wear and tear of the nerve cells.
The collaboration agreement follows a previous agreement between both companies from 2012, and the signature of a memorandum of understanding in 2013 aimed at using Kadimastem's screening platform to characterize new compounds that may lead to next generation neurodegenerative disease therapeutics.
Washington, June 10 ( ANI ): The sleep disorder in particular, called REM behavior disorder, could be a sign of impending neurodegenerative disease, including Parkinson's and dementia, scientists have claimed.
Key words: Alzheimer disease, maneb, manganese, National Children's Study, neurodegenerative disease, paraquat, Parkinson disease, pesticides.
Chair of Neurology at the Methodist Neurological Institute, has completed clinical validation, testing serum proteins from over 600 patients, normal and neurodegenerative disease controls, including patients with Lou Gehrig's (ALS), Alzheimer's and Parkinson's diseases.
Detloff and other investigators have wondered whether almost any protein burdened with additional glutamines would cause a neurodegenerative disease or whether CAG repeats do their damage only in the context of specific genes.
M2 PHARMA-January 9, 2018-Takeda, Denali Partner to Develop, Commercialise Neurodegenerative Disease Therapies
Approximately 5,600 people in the United States are diagnosed each year with ALS, a progressive neurodegenerative disease that is usually fatal within 2-5 years of diagnosis.